Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
企業コードXTNT
会社名Xtant Medical Holdings Inc
上場日Jun 30, 2010
最高経営責任者「CEO」Mr. Sean E. Browne
従業員数217
証券種類Ordinary Share
決算期末Jun 30
本社所在地664 Cruiser Lane
都市BELGRADE
証券取引所NYSE American Consolidated
国United States of America
郵便番号59714
電話番号14063880480
ウェブサイトhttps://xtantmedical.com/
企業コードXTNT
上場日Jun 30, 2010
最高経営責任者「CEO」Mr. Sean E. Browne
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし